Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 Apr 9;23(7):1414–1420. doi: 10.1158/1055-9965.EPI-13-1359

Table 3.

Interactions of IgE measures with age groups and length of time until case diagnosis

Age Interaction p
<65 ≥65
Total IgE
Cases/ Controls 130/247 151/295
Normal 1 1 0.003
Borderline 0.45 (0.26-0.77) 1.43 (0.88-2.32)
Elevated 0.71 (0.41-1.24) 1.98 (1.16-3.37)
IgE to respiratory allergens
Cases/ Controls 130/247 153/295
Negative 1 1 0.25
Positive 0.94 (0.58-1.53) 1.39 (0.89-2.18)
IgE to food allergens
Cases/ Controls 130/247 153/294
Negative 1 1 0.03
Positive 0.80 (0.34-1.91) 2.83 (1.29-6.20)
Years between enrollment and diagnosis
0-5 Years 6-9 Years 10-15 Years
Total IgE
Cases/ Controls 98/188 105/200 78/154
Normal 1 1 1
Borderline 0.64 (0.35-1.17) 1.14 (0.64-2.01) 0.79 (0.40-1.55) 0.63
Elevated 1.26 (0.66-2.41) 1.45 (0.77-2.76) 0.96 (0.49-1.91)
IgE to respiratory allergens
Cases/ Controls 98/188 107/200 78/154
Negative 1 1 1 0.36
Positive 1.37 (0.76-2.46) 1.35 (0.80-2.28) 0.80 (0.43-1.48)
IgE to food allergens
Cases/ Controls 98/188 107/200 78/153
Negative 1 1 1 0.98
Positive 1.47 (0.53-4.07) 1.56 (0.64-3.81) 1.68 (0.63-4.48)

Stratum-specific odds ratios estimated using conditional logistic regression models with interaction terms and adjusting for smoking (for total IgE and IgE to respiratory allergens; never, former quit >15 years ago, former quit <15 years ago, current) or study center (for IgE to food allergens)